Emerson Wealth’s Cardinal Health CAH Stock Holding History

Emerson Wealth’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150	Closed	-$8K	–	60
2021 Q4	$8K	Buy	+150	New	+$7.36K	﹤0.01%	45

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerson Wealth's CAH Position: Q1 2022 in Review

Emerson Wealth sold out of Cardinal Health (CAH) in Q1 2022, closing a stake of 150 shares — an estimated $8K sold.

Emerson Wealth first reported a position in CAH in Q4 2021 and held it in 1 quarter. The position peaked at $8K in Q4 2021. 784 funds tracked by Wall St. Rank hold CAH as of Q1 2022.

Emerson Wealth reported no remaining Cardinal Health position as of Q1 2022 after selling out during the quarter.
Emerson Wealth sold 150 Cardinal Health shares in Q1 2022, an estimated $8K.
Emerson Wealth first reported a position in Cardinal Health in Q4 2021 and held it in 1 quarter.
Emerson Wealth's Cardinal Health position peaked at $8K in Q4 2021.
784 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2022.

Based on Emerson Wealth's 13F filing for Q1 2022, filed 25 Apr 2022.